These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

908 related articles for article (PubMed ID: 34715817)

  • 1. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
    Tang W; Xu F; Zhao M; Zhang S
    BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma.
    Xu F; Zhang Z; Zhao Y; Zhou Y; Pei H; Bai L
    Gene; 2021 Aug; 795():145804. PubMed ID: 34175402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squalene epoxidase promotes breast cancer progression by regulating CCNB1 protein stability.
    Tuluhong D; Gao H; Li X; Wang L; Zhu Y; Xu C; Wang J; Li H; Li Q; Wang S
    Exp Cell Res; 2023 Dec; 433(1):113805. PubMed ID: 37839786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a ferroptosis-related gene signature predictive of prognosis in breast cancer.
    Liu Q; Ma JY; Wu G
    Aging (Albany NY); 2021 Sep; 13(17):21385-21399. PubMed ID: 34499616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi-omics study.
    Xu F; Guan Y; Xue L; Zhang P; Li M; Gao M; Chong T
    Cancer Med; 2021 Dec; 10(24):9078-9096. PubMed ID: 34761566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research.
    Bai Z; Xu F; Feng X; Wu Y; Lv J; Shi Y; Pei H
    Bioengineered; 2022 Jan; 13(1):1717-1735. PubMed ID: 35000541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer.
    Zhong J; Shen X; Zhou J; Yu H; Wang B; Sun J; Wang J; Liu F
    Front Oncol; 2023; 13():1077342. PubMed ID: 36998462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
    Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel ferroptosis-related long noncoding RNA signature for relapse free survival prediction in patients with breast cancer.
    Wang Y; Xu Y; Zhang Y
    Medicine (Baltimore); 2022 Aug; 101(31):e29573. PubMed ID: 35945765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer.
    Xu L; Wang S; Zhang D; Wu Y; Shan J; Zhu H; Wang C; Wang Q
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16511-16523. PubMed ID: 37712959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma.
    Zhao Y; Song Q; Xu F; Zhou Y; Zuo X; Zhang Z
    Front Genet; 2022; 13():823443. PubMed ID: 35368686
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
    Xu L; Zheng Q; Liu W
    BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma.
    Zhou K; Yang J; Li X; Xiong W; Zhang P; Zhang X
    Front Surg; 2022; 9():893977. PubMed ID: 35784919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer.
    Shen C; Chai W; Han J; Zhang Z; Liu X; Yang S; Wang Y; Wang D; Wan F; Fan Z; Hu H
    Front Immunol; 2023; 14():1213947. PubMed ID: 37965307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying subtypes and developing prognostic models based on N6-methyladenosine and immune microenvironment related genes in breast cancer.
    Wang L; Li J; Mei N; Chen H; Niu L; He J; Wang R
    Sci Rep; 2024 Jul; 14(1):16586. PubMed ID: 39020010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
    Wang F; Chen C; Chen WP; Li ZL; Cheng H
    Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
    Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
    Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 46.